𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal anti-CD52 antibodies: a potential mode of therapy for parvovirus B19 hepatitis

✍ Scribed by E Granot; H Miskin; M Aker


Book ID
117230912
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
74 KB
Volume
33
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


In vivo CAMPATH-1 monoclonal antibodies:
✍ Varadi, Gabor; Or, Reuven; Slavin, Shimon; Nagler, Arnon πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 2 views

CHOP, COP plui doxorubicin. ,'According to NCI criteria (Cheson el al. 151). (PD) was registered in one patient. Median time to disease progression for patients in PR or SD was 9 months (range, 1-14 months) (Table I). The results of the prehent study, although based on a small number of patients,